{"url_path":"/sec/grtx/8-k/2026-05-15/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1563577/0001193125-26-225174-index.html","accession_number":"0001193125-26-225174","cik":"0001563577","ticker":"GRTX","issuer_name":"Galera Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1563577/0001193125-26-225174-index.html","primary_entity_key":"0001563577","primary_entity_name":"Galera Therapeutics, Inc."},"word_count":264,"has_tables":true,"body_markdown":"Item 5.03\n\nAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.\n\nOn May 11, 2026, Galera Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company’s common stock from 200 million shares to 400 million shares (the “Stock Increase Charter Amendment”).\n\nOn May 12, 2026, the Company filed a Certificate of Amendment to the Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to provide stockholders with a right to act by written consent (the “Written Consent Charter Amendment”).\n\nBoth the Stock Increase Charter Amendment and the Written Consent Charter Amendment were approved by the Company’s stockholders at the Company’s Annual Meeting of Stockholders held on May 8, 2026.\n\nAlso on May 12, 2026, the Board of Directors of the Company approved and adopted Amended and Restated Bylaws of the Company, effective immediately. The Amended and Restated Bylaws provide stockholders with a written consent right and sets forth certain procedures associated therewith, consistent with the Written Consent Charter Amendment.\n\nThe foregoing descriptions of the Stock Increase Charter Amendment, the Written Consent Charter Amendment and the Amended and Restated Bylaws do not purport to be complete and are qualified in their entirety by reference to the full text of the Stock Increase Charter Amendment, the Written Consent Charter Amendment and the Amended and Restated Bylaws, copies of which are filed as Exhibits 3.1, 3.2 and 3.3 hereto, respectively, and incorporated herein by reference."}